Enovis (ENOV) Income from Continuing Operations (2010 - 2026)
Enovis (ENOV) posted quarterly Income from Continuing Operations of 8411000.0 for Q2 2026, up 84.87% year-over-year from 4549760.87 in Q2 2025, and up 98.38% quarter-over-quarter from 518803000.0 in Q4 2025.
Enovis (ENOV) Income from Continuing Operations (2010 - 2026) Analysis & Trends
Enovis (ENOV) has reported Income from Continuing Operations for 17 consecutive years, with 8411000.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Income from Continuing Operations rose 84.87% year-over-year to 8411000.0; the TTM figure through Apr 2026 stood at 1134542000.0 (down 39.87% YoY), while the FY2025 annual figure was 1181711000.0, down 42.82% from the prior year.
- Income from Continuing Operations advanced to 8411000.0 in Q2 2026 per ENOV's latest filing, from 518803000.0 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 120651000.0 in Q3 2022 and bottomed at 703626000.0 in Q4 2024.
- Historically, Income from Continuing Operations has averaged 124095000.0 across 5 years, with a median of 36455000.0 in 2025.
- Annual changes were most pronounced in 2022 — Income from Continuing Operations surged 386.58% — and 2024, when it tumbled 23034.35%.
- Enovis' Income from Continuing Operations stood at 54840000.0 in 2022, then soared by 105.59% to 3068000.0 in 2023, then sank by 23034.35% to 703626000.0 in 2024, then increased by 26.27% to 518803000.0 in 2025, then surged by 98.38% to 8411000.0 in 2026.
- Business Quant data shows ENOV's Income from Continuing Operations at 8411000.0 in Q2 2026, 518803000.0 in Q4 2025, and 570873000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.44 Bn | 193.84 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 127.32 Bn | 123.85 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 51.90 Bn | 47.65 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.30 Bn | 32.36 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 33.74 Bn | 31.63 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.05 Bn | 22.56 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Enovis | 1.51 Bn | 1.49 Bn | 359.25 Mn | -1.04 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 3, 2026 | -1.04 Mn |
| Apr 3, 2026 | -8.41 Mn |
| Dec 31, 2025 | -518.80 Mn |
| Oct 3, 2025 | -570.87 Mn |
| Jul 4, 2025 | -36.46 Mn |
| Apr 4, 2025 | -55.58 Mn |
| Dec 31, 2024 | -703.63 Mn |
| Sep 27, 2024 | -33.51 Mn |
| Jun 28, 2024 | -18.44 Mn |
| Mar 29, 2024 | -71.84 Mn |
| Dec 31, 2023 | 3.07 Mn |
| Sep 29, 2023 | -19.45 Mn |
| Jun 30, 2023 | -14.61 Mn |
| Mar 31, 2023 | -22.85 Mn |
| Dec 31, 2022 | -54.84 Mn |
| Sep 30, 2022 | -65.95 Mn |
| Jul 1, 2022 | 120.65 Mn |
| Apr 1, 2022 | -38.10 Mn |
| Dec 31, 2021 | -14.70 Mn |
| Oct 1, 2021 | -13.55 Mn |